Evogene(EVGN)

0.7500 0.0148 2.0131%

今开:0.7282昨收:0.7352
最高:0.769899 最低:0.7282
涨停价:0.0跌停价:0.0
总市值:3.7967459E7

Evogene的热门讨论

财报披露

Evogene(EVGN)今天 04:55

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001150  Act: 34  Size: 283 KB 网页链接查看全文

年度财报

Evogene(EVGN)03-28 21:25

$Evogene(EVGN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001137  Act: 34  Size: 19 MB 网页链接查看全文

招股说明书

Evogene(EVGN)今天 05:05

$Evogene(EVGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001152  Act: 33  Size: 899 KB 网页链接查看全文

财报披露

Evogene(EVGN)03-20 21:05

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000995  Act: 34  Size: 32 KB 网页链接查看全文

财报披露

Evogene(EVGN)03-07 20:05

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000857  Act: 34  Size: 476 KB 网页链接查看全文

增发股票注册声明

Evogene(EVGN)03-01 20:05

$Evogene(EVGN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001178913-24-000782  Act: 33  Size: 1 MB 网页链接查看全文

财报披露

Evogene(EVGN)02-22 20:05

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000687  Act: 34  Size: 36 KB 网页链接查看全文

Benson Hill战略演进!大豆加工工厂剥离!着眼轻资产创新之路!

知耕TechCube02-26 15:42

大|企|业|动|向
Big Player
Benson Hill剥离大豆加工工厂向轻资产业务模式转型
Yield10加速推进Omega-3亚麻荠项目商业化
ScotBio开发藻蓝蛋白培育和纯化系统
Verb Biotics携手Evogene开发特性微生物代谢物
Pivot Bio与爱荷华州立大学合建可持续农业先进中心
三菱...查看全文

财报披露

Evogene(EVGN)02-21 20:05

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000670  Act: 34  Size: 36 KB 网页链接查看全文

超过5%股东持股披露

Evogene(EVGN)02-15 09:35

$Evogene(EVGN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001999371-24-002373  Act: 34  Size: 99 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Evogene的新闻

融资丨「Biomica」完成新一轮融资,上海生物医药基金与Evogene联合投资

本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接

Evogene的公告

招股说明书

$Evogene(EVGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001152  Act: 33  Size: 899 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001150  Act: 34  Size: 283 KB 网页链接

年度财报

$Evogene(EVGN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001137  Act: 34  Size: 19 MB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000995  Act: 34  Size: 32 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000857  Act: 34  Size: 476 KB 网页链接

增发股票注册声明

$Evogene(EVGN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001178913-24-000782  Act: 33  Size: 1 MB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000687  Act: 34  Size: 36 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000670  Act: 34  Size: 36 KB 网页链接

超过5%股东持股披露

$Evogene(EVGN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001999371-24-002373  Act: 34  Size: 99 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000179  Act: 34  Size: 31 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30